A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)

Name: A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
Published: 2014
License: Public Domain

Merck Sharp & Dohme LLC · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

chemotherapy paclitaxel

non-small cell lung carcinoma, pd-1, pd1, programmed cell death-1, programmed cell death 1, chemotherapy, pemetrexed, paclitaxel, bevacizumab, erlotinib, gefitinib, ipilimumab

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 843087
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.